Glossary

📍 Quick reference: This is your pocket dictionary for the whole journey. Bookmark it and come back anytime a word stops making sense.

Every field has its own language, and biologic manufacturing has a lot of it. Here are the most important terms from this guide, in plain words, listed alphabetically so they are easy to find.

Aggregate — Antibody molecules that have clumped together into bigger particles, which can be unsafe and must be removed.

Aseptic — A way of working that keeps germs out, used when the product cannot be sterilized later.

At-line — A measurement made right next to the process, on a quick sample, so results come back fast.

Batch / Lot — One single run of the process; everything made together that shares the same history and quality record.

Biologic — A medicine made by living cells, usually a large, complex protein rather than a simple chemical.

Biosimilar — A near-copy of an already-approved biologic, made by a different company after the original patent ends.

Bioreactor — A controlled tank where living cells are grown to make the medicine.

Capture — The first big purification step, which grabs the antibody out of a messy mixture and leaves most junk behind.

Cell bank (MCB/WCB) — Frozen, identical copies of the factory cell; the Master Cell Bank (MCB) is the original treasure, the Working Cell Bank (WCB) is the everyday stock made from it.

Cell line — A population of identical cells, all descended from one chosen cell, used to make the product.

CHO cells — Chinese Hamster Ovary cells, the most common living factories used to make antibody medicines.

Chromatography — A purification method that separates molecules by how strongly they stick to special beads inside a column.

Clarification — Cleaning the cloudy liquid after harvest by removing cells and debris, leaving a clear fluid.

Clone / Clonality — A clone is a group of cells all descended from one single cell; clonality is the proof that they truly came from just one.

Cold chain — The unbroken chain of refrigeration that keeps the medicine cold from factory to patient.

CPP (Critical Process Parameter) — A setting in the process, such as temperature, that must stay in range to keep quality right.

CQA (Critical Quality Attribute) — A property of the product, such as purity, that must hit its target for the medicine to be safe and to work.

Diafiltration — Washing a protein solution by swapping its liquid for the final, gentle buffer the medicine needs.

Dissolved oxygen (DO) — The amount of oxygen in the liquid, which living cells need to breathe and stay healthy.

DOE (Design of Experiments) — A smart way of testing many settings at once to learn the best recipe with fewer experiments.

Downstream — The second half of making the medicine: purifying the antibody after the cells have made it.

Drug product (DP) — The finished medicine in its final form, such as a filled vial or syringe, ready for a patient.

Drug substance (DS) — The pure, concentrated antibody before it is put into its final vial; the active ingredient.

Elution — The step that releases the captured antibody from the column so it flows out clean.

Endotoxin — A toxic substance from certain bacteria that can cause fever and must be kept extremely low.

Excipient — A helper ingredient, such as sugar or salt, added to keep the protein stable and comfortable.

Fed-batch — The standard way to grow cells, feeding them extra nutrients over time in one big tank, then harvesting once.

Fill-finish — The final stage where the pure medicine is filled into vials or syringes, sealed, and inspected.

Formulation — The recipe of the final liquid, choosing the right excipients so the medicine stays stable and safe to inject.

GMP / cGMP — Good Manufacturing Practice, the strict, legally required rules for making medicine safely and consistently.

Glycan — A sugar chain attached to the antibody that strongly affects how well and how safely it works.

Harvest — Collecting the medicine-rich liquid from the bioreactor once the cells have done their job.

Host cell protein (HCP) — Leftover proteins from the factory cells that must be cleaned out of the final medicine.

IND / BLA — An IND (Investigational New Drug) is the application to start human testing; a BLA (Biologics License Application) is the request to sell the approved medicine.

Lyophilization — Freeze-drying the medicine into a stable powder that is mixed with liquid again before use.

Monoclonal antibody (mAb) — A single, precisely targeted antibody made in huge identical copies to treat disease.

PAT (Process Analytical Technology) — Tools that measure the process as it runs, so problems are caught and fixed in real time.

Perfusion — A modern way to grow cells where fresh food flows in and product flows out continuously, keeping cells productive for weeks.

Polishing — The final purification steps that remove the last tiny impurities, such as aggregates.

Potency — A measure of how strongly the medicine does its job, confirming the product truly works.

Process development — The lab work of inventing and perfecting the recipe before making medicine at full scale.

Protein A — A special material that grabs antibodies very selectively, used in the platform capture step.

QA (Quality Assurance) — The team and system that build quality into every step and decide whether a batch can be released.

QC (Quality Control) — The lab that tests samples to confirm the product meets its quality targets.

Resin / Column — The resin is the tiny purifying beads; the column is the tube that holds them so liquid can flow through.

Seed train — Growing the cells in a series of ever-larger flasks and tanks to build enough of them for the big bioreactor.

Serialization — Giving each pack a unique code so it can be tracked and proven genuine, fighting counterfeits.

Single-use — Equipment made of sterile plastic, used once and thrown away, which avoids cleaning and cross-contamination.

Sterile filtration — Pushing the liquid through a filter so fine it removes bacteria, making the product germ-free.

Tech transfer — Handing the recipe and know-how from the lab to the factory so it can be made at large scale.

Titer — How much antibody the cells make per liter of liquid; higher titer means a more productive process.

Upstream — The first half of making the medicine: growing the cells so they produce the antibody.

UF/DF — Ultrafiltration and Diafiltration, the step that concentrates the antibody and swaps in the final buffer.

Viral clearance — The overall ability of the process to remove or kill viruses, proven across several steps.

Viral filtration — Pushing the liquid through an ultra-fine filter that physically traps viruses.

Viral inactivation — A step, often a short time at low pH, that destroys any viruses that might be present.

If a term here still feels fuzzy, follow it back into the chapter where it lives, and it will make far more sense in context.